References
- Artyushin, O. I., Sharova, E. V., Vinogradova, N. M., Genkina, G. K., Moiseeva, A. A., Klemenkova, Z. S., Orshanskaya, I. R., Shtro, A. A., Kadyrova, R. A., Zarubaev, V. V., Yarovaya, O. I., Salakhutdinov, N. F., & Brel, V. K. (2017). Synthesis of camphecene derivatives using click chemistry methodology. Bioorganic & Medicinal Chemistry Letters, 27(10), 2181–2184. https://doi.org/https://doi.org/10.1016/j.bmcl.2017.03.051
- Basu, A., Antanasijevic, A., Wang, M., Li, B., Mills, D. M., Ames, J. A., Nash, P. J., Williams, J. D., Peet, N. P., Moir, D. T., Prichard, M. N., Keith, K. A., Barnard, D. L., Caffrey, M., Rong, L., & Bowlin, T. L. (2014). New small molecule entry inhibitors targeting hemagglutinin-mediated influenza A virus fusion. Journal of Virology, 88(3), 1447–1460. https://doi.org/https://doi.org/10.1128/JVI.01225-13
- Behera, A. K., Chandra, I., & Cherian, S. S. (2016). Molecular dynamics simulation of the effects of single (S221P) and double (S221P and K216E) mutations in the hemagglutinin protein of influenza A H5N1 virus: A study on host receptor specificity. Journal of Biomolecular Structure and Dynamics, 34(9), 2054–2067. https://doi.org/https://doi.org/10.1080/07391102.2015.1106341
- Benton, D. J., Gamblin, S. J., Rosenthal, P. B., & Skehel, J. J. (2020). Structural transitions in influenza haemagglutinin at membrane fusion pH. Nature, 583(7814), 150–153. https://doi.org/https://doi.org/10.1038/s41586-020-2333-6
- Benton, D. J., Nans, A., Calder, L. J., Turner, J., Neu, U., Pu Lin, Y., Ketelaars, E., Kallewaard, N. L., Corti, D., Lanzavecchia, A., Gamblin, S. J., Rosenthal, P. B., & Skehel, J. J. (2018). Influenza hemagglutinin membrane anchor. Proceedings of the National Academy of Sciences of the United States of America, 115(40), 10112–10117. https://doi.org/https://doi.org/10.1073/pnas.1810927115
- Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N., & Bourne, P. E. (2000). The protein data bank. Nucleic Acids Research, 28(1), 235–242. https://doi.org/https://doi.org/10.1093/nar/28.1.235
- Bochevarov, A. D., Harder, E., Hughes, T. F., Greenwood, J. R., Braden, D. A., Philipp, D. M., Rinaldo, D., Halls, M. D., Zhang, J., & Friesner, R. A. (2013). Jaguar: A high-performance quantum chemistry software program with strengths in life and materials sciences. International Journal of Quantum Chemistry, 113(18), 2110–2142. https://doi.org/https://doi.org/10.1002/qua.24481
- Bochevarov, A. D., Watson, M. A., Greenwood, J. R., & Philipp, D. M. (2016). Multiconformation, density functional theory-based pKa prediction in application to large, flexible organic molecules with diverse functional groups. Journal of Chemical Theory and Computation, 12(12), 6001–6019. https://doi.org/https://doi.org/10.1021/acs.jctc.6b00805
- Bruno, V. B., Baptista, A. M., & Soares, C. M. (2012). Structural determinants for the membrane insertion of the transmembrane peptide of hemagglutinin from influenza virus. Journal of Chemical Information and Modeling, 52, 3001–3012.
- Bruno, V. L., Lousa, D., Antunes, J. M., & Soares, C. M. (2015). Self-assembly molecular dynamics simulations shed light into the interaction of the influenza fusion peptide with a membrane bilayer. Journal of Chemical Information and Modeling, 55, 795–805.
- Chernomordik, L. V., & Kozlov, M. M. (2003). Protein-lipid interplay in fusion and fission of biological membranes. Annual Review of Biochemistry, 72, 175–207. https://doi.org/https://doi.org/10.1146/annurev.biochem.72.121801.161504
- Cho, K. J., Lee, J.-H., Hong, K. H., Kim, S.-H., Park, Y., Lee, J. Y., Kang, S., Kim, S., Yang, J. H., Kim, E.-K., Seok, J. H., Unzai, S., Park, S. Y., Saelens, X., Kim, C.-J., Lee, J.-Y., Kang, C., Oh, H.-B., Chung, M. S., & Kim, K. H. (2013). Insight into structural diversity of influenza virus haemagglutinin. The Journal of General Virology, 94(Pt 8), 1712–1722. https://doi.org/https://doi.org/10.1099/vir.0.051136-0
- Das, D. K., Govindan, R., Nikić-Spiegel, I., Krammer, F., Lemke, E. A., & Munro, J. B. (2018). Direct visualization of the conformational dynamics of single influenza hemagglutinin trimers. Cell, 174(4), 926–937. https://doi.org/https://doi.org/10.1016/j.cell.2018.05.050
- Demicheli, V., Jefferson, T., Pietrantonj, D. C., Ferroni, E., Thorning, S., Tomas, R. E., & Rivetti, A. (2018). Vaccines for preventing influenza in the elderly. Cochrane Database of Systematic Reviews, 2, 1–18.
- Fiore, A. E., Bridges, C. B., & Cox, N. J. (2009a). Seasonal influenza vaccines. Current Topics in Microbiology and Immunology, 333, 43–82.
- Fiore, A. E., Shay, D. K., Broder, K., Iskander, J. K., Uyeki, T. M., Mootrey, G., Bresee, J. S., & Cox, N. J. (2009b). Prevention and control of seasonal influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and Reports, 58, 896–912.
- Gamblin, S. J., Haire, L. E., Russell, R. J., Stevens, D. J., Xiao, B., Ha, Y., Vasisht, N., Steinhauer, D. A., Daniels, R. S., Elliot, A., Wiley, D. C., & Skehel, J. J. (2004). The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science (New York, N.Y.), 303(5665), 1838–1842. https://doi.org/https://doi.org/10.1126/science.1093155
- Guan, S., Wang, T., Kuai, Z., Qian, M., Tian, X., Zhang, X., Yu, Y., Wang, S., Zhang, H., Li, H., Kong, W., & Shan, Y. (2017). Exploration of binding and inhibition mechanism of a small molecule inhibitor of influenza virus H1N1 hemagglutinin by molecular dynamics simulation. Scientific Reports, 7(1), 3786. https://doi.org/https://doi.org/10.1038/s41598-017-03719-4
- Hamilton, B. S., Whittaker, G. R., & Daniel, S. (2012). Influenza virus-mediated membrane fusion: Determinants of hemagglutinin fusogenic activity and experimental approaches for assessing virus fusion. Viruses, 4(7), 1144–1168. https://doi.org/https://doi.org/10.3390/v4071144
- Hayden, F. G., Sugaya, N., Hirotsu, N., Lee, N., de Jong, M. D., Hurt, A. C., Ishida, T., Sekino, H., Yamada, K., Portsmouth, S., Kawaguchi, K., Shishido, T., Arai, M., Tsuchiya, K., Uehara, T., & Watanabe, A. (2018). Baloxavir Marboxil Investigators group: Baloxavir Marboxil for uncomplicated influenza in adults and adolescents. New England Journal of Medicine, 379(10), 913–923. https://doi.org/https://doi.org/10.1056/NEJMoa1716197
- Henderson, H. J. (1908). Concerning the relationship between the strength of acids and their capacity to preserve neutrality. American Journal of Physics., 21(2), 173–179. https://doi.org/https://doi.org/10.1152/ajplegacy.1908.21.2.173
- Kielian, M., & Rey, F. A. (2006). Virus membrane-fusion proteins: More than one way to make a hairpin. Nature Reviews Microbiology, 4(1), 67–76. https://doi.org/https://doi.org/10.1038/nrmicro1326
- Lee, S. M., & Yen, H.-L. (2012). Targeting the host or the virus: Current and novel concepts for antiviral approaches against influenza virus infection. Antiviral Research, 96(3), 391–404. https://doi.org/https://doi.org/10.1016/j.antiviral.2012.09.013
- Leiva, R., Barniol-Xicota, M., Codony, S., Ginex, T., Vanderlinden, E., Montes, M., Caffrey, M., Luque, F. J., Naesens, L., & Vázquez, S. (2018). Aniline-based inhibitors of influenza H1N1 virus acting on hemagglutinin-mediated fusion. Journal of Medicinal Chemistry, 61(1), 98–118. https://doi.org/https://doi.org/10.1021/acs.jmedchem.7b00908
- Lin, X., Noel, J. K., Wang, Q., Ma, J., & Onuchic, J. N. (2018). Atomistic simulations indicate the functional loop-to-coiled-coil transition in influenza hemagglutinin is not downhill. Proceedings of the National Academy of Sciences of the United States of America, 115(34), E7905–E7913. https://doi.org/https://doi.org/10.1073/pnas.1805442115
- Newhouse, I. E., Xu, D., Markwick, P. R., Amaro, R. E., Pao, H. C., Wu, K. J., Alam, M., McCammon, A. J., & Li, W. W. (2009). Mechanism of glycan receptor recognition and specificity switch for avian, swine, and human adapted influenza virus hemagglutinins: A molecular dynamics perspective. Journal of the American Chemical Society, 131(47), 17430–17442. https://doi.org/https://doi.org/10.1021/ja904052q
- OriginLab. (1999). Origin, version 6. OriginLab Corporation.
- Porotto, M., Yokoyama, C. C., Palermo, L. M., Mungall, B., Aljofan, M., Cortese, R., Pessi, A., & Moscona, A. (2010). Viral entry inhibitors targeted to the membrane site of action. Journal of Virology, 84(13), 6760–6768. https://doi.org/https://doi.org/10.1128/JVI.00135-10
- Russell, R. J., Kerry, P. S., Stevens, D. J., Steinhauer, D. A., Martin, S. R., Gamblin, S. J., & Skehel, J. J. (2008). Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion. Proceedings of the National Academy of Sciences of the United States of America, 105(46), 17736–17741. https://doi.org/https://doi.org/10.1073/pnas.0807142105
- Schrödinger Release 2018-4. (2018). Schrödinger, LLC.
- Shivakumar, D., Harder, E., Damm, W., Friesner, R. A., & Sherman, W. (2012). Improving the prediction of absolute solvation free energies using the Next Generation OPLS force field. Journal of Chemical Theory and Computation, 8(8), 2553–2558. https://doi.org/https://doi.org/10.1021/ct300203w
- Sokolova, A. S., Yarovaya, O. I., Shernyukov, A. V., Gatilov, Y. V., Razumova, Y. V., Zarubaev, V. V., Tretiak, T. S., Pokrovsky, А. G., Kiselev, O. I., & Salakhutdinov, N. F. (2015). Discovery of a new class of antiviral compounds: Camphor imine derivatives. European Journal of Medicinal Chemistry, 105, 263–273. https://doi.org/https://doi.org/10.1016/j.ejmech.2015.10.010
- Taubenberger, J. K., & Morens, D. M. (2007). The pathology of influenza virus infections. Annual Review of Pathology, 3, 449–524.
- van der Vries, E., Collins, P. J., Vachieri, S. G., Xiong, X., Liu, J., Walker, P. A., Haire, L. F., Hay, A. J., Schutten, M., Osterhaus, A. D. M. E., Martin, S. R., Boucher, C. A. B., Skehel, J. J., & Gamblin, S. J. (2012). H1N1 2009 pandemic influenza virus: Resistance of the I223R neuraminidase mutant explained by kinetic and structural analysis. PLoS Pathogens, 8(9), e1002914 https://doi.org/https://doi.org/10.1371/journal.ppat.1002914
- van Poelvoorde, L. A., Saelens, X., Thomas, I., & Roosens, N. (2020). Next-generation sequencing: An eye-opener for the surveillance of antiviral resistance in Influenza. Trends in Biotechnology, 38(4), 360–367. https://doi.org/https://doi.org/10.1016/j.tibtech.2019.09.009
- Weis, W. I., Brünger, A. T., Skehel, J. J., & Wiley, D. C. (1990). Refinement of the influenza virus hemagglutinin by simulated annealing. Journal of Molecular Biology, 212(4), 737–761. https://doi.org/https://doi.org/10.1016/0022-2836(90)90234-D
- Xu, R., & Wilson, I. A. (2011). Structural characterization of an early fusion intermediate of influenza virus hemagglutinin. Journal of Virology, 85(10), 5172–5182. https://doi.org/https://doi.org/10.1128/JVI.02430-10
- Yarovaya, O. I., Sokolova, A. S., Mainagashev, I. Y., Volobueva, A. S., Lantseva, K., Borisevich, S. S., Shtro, A. A., Zarubaev, V. V., & Salakhutdinov, N. F. (2019). Synthesis and structure-activity relationships of novel camphecene analogues as anti-influenza agents. Bioorganic & Medicinal Chemistry Letters, 29(23), 126745. https://doi.org/https://doi.org/10.1016/j.bmcl.2019.126745
- Yusuf, M., Konc, J., Sy Bing, C., Konc, J. T., Khairudin, A. N. B., Janezic, D., & Wahab, H. A. (2013). Structurally conserved binding sites of hemagglutinin as targets for influenza drug and vaccine development. Journal of Chemical Information and Modeling, 53(9), 2423–2436. https://doi.org/https://doi.org/10.1021/ci400421e
- Zarubaev, V. V., Garshinina, A. V., Tretiak, T. S., Fedorova, V. A., Shtro, A. A., Sokolova, A. S., Yarovaya, O. I., & Salakhutdinov, N. F. (2015). Broad range of inhibiting action of novel camphor-based compound with anti-hemagglutinin activity against influenza viruses in vitro and in vivo. Antiviral Research, 120, 126–133. https://doi.org/https://doi.org/10.1016/j.antiviral.2015.06.004
- Zarubaev, V. V., Pushkina, E. A., Borisevich, S. S., Galochkina, A. V., Garshinina, A. V., Shtro, A. A., Egorova, A. A., Sokolova, A. S., Khursan, S. L., Yarovaya, O. I., & Salakhutdinov, N. F. (2018). Selection of influenza virus resistant to the novel camphor-based antiviral camphecene results in loss of pathogenicity. Virology, 524, 69–77. https://doi.org/https://doi.org/10.1016/j.virol.2018.08.011